185 related articles for article (PubMed ID: 6280605)
21. Inhibition of human herpesviruses by combination of acyclovir and human leukocyte interferon.
Levin MJ; Leary PL
Infect Immun; 1981 Jun; 32(3):995-9. PubMed ID: 6166569
[TBL] [Abstract][Full Text] [Related]
22. Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine.
Larsson A; Alenius S; Johansson NG; Oberg B
Antiviral Res; 1983 Aug; 3(2):77-86. PubMed ID: 6312878
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of oral acyclovir therapy.
Fletcher C; Bean B
Drug Intell Clin Pharm; 1985; 19(7-8):518-24. PubMed ID: 2992899
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine).
Smith KO; Kennell WL; Poirier RH; Lynd FT
Antimicrob Agents Chemother; 1980 Feb; 17(2):144-50. PubMed ID: 6247967
[TBL] [Abstract][Full Text] [Related]
25. Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses.
Pagano JS; Datta AK
Am J Med; 1982 Jul; 73(1A):18-26. PubMed ID: 6285710
[TBL] [Abstract][Full Text] [Related]
26. Update on herpesvirus infections.
Griffiths P
J R Coll Physicians Lond; 1998; 32(3):199-202. PubMed ID: 9670143
[No Abstract] [Full Text] [Related]
27. Therapy for human herpesvirus infections. A perspective.
Whitley RJ
Ala J Med Sci; 1985 Apr; 22(2):193-207. PubMed ID: 2988359
[No Abstract] [Full Text] [Related]
28. 5-(2-Chloroethyl)-2'-deoxyuridine: a potent and selective inhibitor of herpes viruses in vitro and in vivo.
Rosenwirth B; Griengl H; Wanek E; De Clercq E
Antiviral Res; 1985; Suppl 1():20-8. PubMed ID: 3002256
[No Abstract] [Full Text] [Related]
29. In vitro susceptibility of varicella-zoster virus to acyclovir.
Biron KK; Elion GB
Antimicrob Agents Chemother; 1980 Sep; 18(3):443-7. PubMed ID: 6252836
[TBL] [Abstract][Full Text] [Related]
30. Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1.
Cheng YC; Huang ES; Lin JC; Mar EC; Pagano JS; Dutschman GE; Grill SP
Proc Natl Acad Sci U S A; 1983 May; 80(9):2767-70. PubMed ID: 6302704
[TBL] [Abstract][Full Text] [Related]
31. Resistance and latency.
Field HJ
Br Med Bull; 1985 Oct; 41(4):345-50. PubMed ID: 2996685
[No Abstract] [Full Text] [Related]
32. Antiherpes drugs: promises and pitfalls.
de Clercq E
Eur J Clin Microbiol; 1984 Apr; 3(2):96-107. PubMed ID: 6327297
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of herpes virus by a new compound--acyclic guanosine.
Oxford JS
J Antimicrob Chemother; 1979 Jul; 5(4):333-4. PubMed ID: 226511
[No Abstract] [Full Text] [Related]
34. Treatment of human herpesvirus infections with special reference to encephalitis.
Whitley RJ
J Antimicrob Chemother; 1984 Aug; 14 Suppl A():57-74. PubMed ID: 6092319
[No Abstract] [Full Text] [Related]
35. Acyclovir in severe herpes virus infections.
van der Meer JW; Versteeg J
Am J Med; 1982 Jul; 73(1A):271-4. PubMed ID: 7102706
[TBL] [Abstract][Full Text] [Related]
36. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
37. Herpes simplex virus infection.
Chang TW
Int J Dermatol; 1983; 22(1):1-7. PubMed ID: 6299983
[No Abstract] [Full Text] [Related]
38. Acyclovir treatment of herpes simplex virus infections in immunocompromised humans. An overview.
Alford CA
Am J Med; 1982 Jul; 73(1A):225-8. PubMed ID: 6285714
[TBL] [Abstract][Full Text] [Related]
39. Use of acyclovir in herpetic ocular infection.
McGill J; Tormey P
Am J Med; 1982 Jul; 73(1A):286-9. PubMed ID: 7102708
[TBL] [Abstract][Full Text] [Related]
40. Acyclovir treatment of cutaneous herpes in guinea pigs and herpes encephalitis in mice.
Collins P; Oliver NM
Am J Med; 1982 Jul; 73(1A):96-9. PubMed ID: 7102714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
